---
figid: PMC3734934__nihms407257f6
figtitle: Disruption of mindin exacerbates cardiac hypertrophy and fibrosis
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3734934
filename: nihms407257f6.jpg
figlink: /pmc/articles/PMC3734934/figure/F6/
number: F6
caption: . Proposed model of the effects of mindin deficiency on cardiac hypertrophy
  and fibrosis. Mindin deficiency enhances the activation of AKT/GSK3β signalling
  induced by aortic banding or Ang II infusion, which exacerbates cardiac remodelling.
  First, the activated AKT/GSK3β signalling pathway promotes hypertrophic marker expression
  and subsequently results in cardiac hypertrophy. Second, the AKT/GSK3β signalling
  pathway enhances Smad signalling, increases expression of fibrotic markers and leads
  to collagen synthesis and fibrosis. Mindin deficiency enhances these AKT-dependent
  signalling pathways and exacerbates cardiac hypertrophy and fibrosis, which promotes
  the progression of cardiac remodelling and heart failure. Pharmacological inhibition
  of AKT/GSK3β signalling rescues both cardiac hypertrophy and fibrosis in Mindin−/−
  mice in response to hypertrophic stimuli.
papertitle: Disruption of mindin exacerbates cardiac hypertrophy and fibrosis.
reftext: Zhou-Yan Bian, et al. J Mol Med (Berl). ;90(8):895-910.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8453109
figid_alias: PMC3734934__F6
figtype: Figure
redirect_from: /figures/PMC3734934__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3734934__nihms407257f6.html
  '@type': Dataset
  description: . Proposed model of the effects of mindin deficiency on cardiac hypertrophy
    and fibrosis. Mindin deficiency enhances the activation of AKT/GSK3β signalling
    induced by aortic banding or Ang II infusion, which exacerbates cardiac remodelling.
    First, the activated AKT/GSK3β signalling pathway promotes hypertrophic marker
    expression and subsequently results in cardiac hypertrophy. Second, the AKT/GSK3β
    signalling pathway enhances Smad signalling, increases expression of fibrotic
    markers and leads to collagen synthesis and fibrosis. Mindin deficiency enhances
    these AKT-dependent signalling pathways and exacerbates cardiac hypertrophy and
    fibrosis, which promotes the progression of cardiac remodelling and heart failure.
    Pharmacological inhibition of AKT/GSK3β signalling rescues both cardiac hypertrophy
    and fibrosis in Mindin−/− mice in response to hypertrophic stimuli.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MICE
  - SPON2
  - SMAD4
  - SMAD2
  - SMAD3
  - NPPB
  - NPPA
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - CCN2
---
